Amplification of cytokine production through synergistic activation of NFAT and AP-1 following stimulation of mast cells with antigen and IL-33

被引:76
作者
Andrade, Marcus V. [1 ,2 ]
Iwaki, Shoko [1 ]
Ropert, Catherine [4 ]
Gazzinelli, Ricardo T. [4 ]
Cunha-Melo, Jose R. [3 ]
Beaven, Michael A. [1 ]
机构
[1] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA
[2] Univ Fed Minas Gerais, Sch Med, Dept Internal Med, Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Sch Med, Dept Surg, Belo Horizonte, MG, Brazil
[4] Fiocruz MS, Rene Rachou Inst, Immunopathol Lab, Belo Horizonte, MG, Brazil
基金
美国国家卫生研究院;
关键词
Ag; Cytokine; IL-33; Mast Cells; Signaling mechanisms; RECEPTOR ACCESSORY PROTEIN; I-KAPPA-B; INFLAMMATORY MEDIATORS; SIGNALING PATHWAYS; HUMAN BASOPHILS; KINASE TAK1; ST2; IGE; TRANSCRIPTION; RECRUITMENT;
D O I
10.1002/eji.201040718
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-33 is associated with atopic and autoimmune diseases and, as reported here, it interacts synergistically with Ag to markedly enhance production of inflammatory cytokines in rodent mast cells even in the absence of degranulation. Investigation of the underlying mechanisms revealed that synergy in signaling occurred at the level of TGF-beta-activated kinase 1, which was then transmitted downstream through JNK, p38 MAP kinase, and AP-1. Stimulation of the Ca2(+)/calcineurin/NFAT pathway by Ag, which IL-33 did not, was critical for the synergy between Ag and IL-33. For example, selective stimulation of the NFAT pathway by thapsigargin also markedly enhanced responses to IL-33 in a calcineurin-dependent manner. As indicated by luciferase-reporter assays, IL-33 failed to stimulate the transcriptional activities of NFAT and AP-1 but augmented the activation of these transcription factors by Ag or thapsigargin. Robust stimulation of NF-kappa B transcriptional activity by IL-33 was also essential for the synergy. These and pharmacologic data suggested that the enhanced production of cytokines resulted in part from amplification of the activation of AP-1 and NFAT as well as co-operative interactions among transcription factors. IL-33 may retune mast cell responses to Ag toward enhanced cytokine production and thus determine the symptoms and severity of Ag-dependent allergic and autoimmune diseases.
引用
收藏
页码:760 / 772
页数:13
相关论文
共 56 条
[1]   Regulation of the mast cell response to the type 1 Fcε receptor [J].
Abramson, Jakub ;
Pecht, Israel .
IMMUNOLOGICAL REVIEWS, 2007, 217 :231-254
[2]   IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells [J].
Ali, Shafaqat ;
Hubert, Michael ;
Kollewe, Christian ;
Bischoff, Stephan C. ;
Falk, Werner ;
Martin, Michael U. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (47) :18660-18665
[3]   Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells [J].
Allakhverdi, Zouna ;
Smith, Dirk E. ;
Comeau, Michael R. ;
Delespesse, Guy .
JOURNAL OF IMMUNOLOGY, 2007, 179 (04) :2051-2054
[4]   IL-1, IL-18, and IL-33 families of cytokines [J].
Arend, William P. ;
Palmer, Gaby ;
Gabay, Cem .
IMMUNOLOGICAL REVIEWS, 2008, 223 :20-38
[5]   Our perception of the mast cell from Paul Ehrlich to now [J].
Beaven, Michael A. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (01) :11-25
[6]   Expression of the Rap1 Guanine Nucleotide Exchange Factor, MR-GEF, Is Altered in Individuals with Bipolar Disorder [J].
Bithell, Angela ;
Hsu, Tony ;
Kandanearatchi, Apsara ;
Landau, Sabine ;
Everall, Ian P. ;
Tsuang, Ming T. ;
Chana, Gursharan ;
Williams, Brenda P. .
PLOS ONE, 2010, 5 (04)
[7]   IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo [J].
Carriere, Virginie ;
Roussel, Lucie ;
Ortega, Nathalie ;
Lacorre, Delphine-Armelle ;
Americh, Laure ;
Aguilar, Luc ;
Bouche, Gerard ;
Girard, Jean-Philippe .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (01) :282-287
[8]   IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex [J].
Chackerian, Alissa A. ;
Oldham, Elizabeth R. ;
Murphy, Erin E. ;
Schmitz, Jochen ;
Pflanz, Stefan ;
Kastelein, Robert A. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (04) :2551-2555
[9]  
Cissel DS, 1998, J PHARMACOL EXP THER, V285, P110
[10]   A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-κB and NFAT families [J].
de Lumley, M ;
Hart, DJ ;
Cooper, MA ;
Symeonides, S ;
Blackburn, JM .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 339 (05) :1059-1075